Cook Medical offers a variety of regional training opportunities on the Zenith portfolio through the Vista Education and Training Program. Jason Lee, MD, talks about the value of Vista training for both fellows and tenured physicians. Q: Why would you encourage physicians to attend Vista training? A: Vascular surgeons are constantly searching for better ways…

After many of the sessions at Charing Cross 2016, the moderator asked for the audience to weigh in. See how your colleagues answered the poll questions at the meeting. Sign up for our email newsletter Get meeting takeaways, product information, new training opportunities and more sent straight to your inbox. Sign up for our email…

There are many reasons to spend time with Cook Medical during the 2016 Vascular Annual Meeting in Washington, D.C. in June. Here are just three: 1. Sign up for new aortic Vista™ courses!  We’re introducing all new aortic course offerings through our Vista Education and Training program. Throughout the second half out 2016, we’ll be…

At Charing Cross 2016, we want you to get hands on with Zenith Alpha™ Thoracic. You’ll be able to watch an edited live case with the device and try out touchscreen deployment in the Cook booth. Click the infographic to enlarge. Follow @CookEVAR on Twitter to get #CX2016 updates We will be posting live updates from some…

Maximize your seal in the abdominal aorta with a variety of disease-specific Zenith endovascular grafts. View each product’s indications for use, component ordering information, introduction system, and graft specifications. Zenith Flex®: Time-tested durability Zenith Flex combines precise, trigger-wire deployment with time-tested endoleak and migration resistance technology to help you provide a durable repair. Zenith Flex is available with…

The podium presentations at the 2016 SCVS Annual Symposium were filled with valuable clinical advice and considerations, especially for fellows and residents. Here are some of our top takeaways from the presentations: Be prepared for emergencies as a fellow. Dr. Brant Ullery shared the top five emergencies that a fellow could be faced with, and…

Cook Medical mourns the death of a cherished friend, respected vascular surgeon, inventor, and one of the true pioneers of endovascular repair for complex aortic aneurysms, Dr. John Anderson. The following reflection was contributed by John’s close friend and colleague, David Hartley. Very early in his vascular surgery career, John recognized the advantages and exciting…

Dr. Jason T. Lee, professor of surgery and program director at Stanford University, has a vested interest in helping educate incoming vascular surgery fellows, residents, and young surgeons in practice. Whether he’s giving advice on how to run an efficient service, discussing aorta basics, doing hands-on demonstrations, or proctoring complex interventions, Dr. Lee recognizes the…

At Cook, we believe that it is our responsibility to partner with physicians to help improve patient outcomes by developing endovascular grafts that are designed for long-term durability. The now commercially available Zenith Alpha Thoracic Endovascular Graft is the culmination of everything we have learned in more than 20 years of EVAR. Learn more about…

Cook offers disease-specific treatment options that are designed to help you provide a durable repair in the thoracic aorta. View each product’s indications for use, component ordering information, introduction system, and graft specifications by clicking the links below. Zenith Alpha™ Thoracic: Intuitive, low-profile design With a low-profile delivery system and a broad range of lengths and…

The Zenith Alpha™ Thoracic Endovascular Graft is now commercially available in the U.S., following premarket approval from the U.S. Food and Drug Administration in 2015.   With a 16-20 Fr delivery system, Zenith Alpha Thoracic was developed to provide vascular access and delivery with a lower profile device which allows physicians to consider TEVAR (thoracic…

The years of your fellowship or residency will go by quickly, and it can be difficult to find the time to supplement your formal training. But it can be extremely valuable. Adjunctive training offers the opportunity for cross-specialty skill building, both in a didactic and hands-on setting. Here are 10 reasons to sign up for…

This year’s VEITHsymposium® was filled with presentations on new developments in the treatment of aortic disease from the world’s leading physicians. If you weren’t able to be there, here are our top 10 takeaways from the meeting. Don’t skimp on the neck. Device failure is often caused by an issue with the proximal landing zone….

Abstract Cook is pleased to provide you with this clinical update on the Zenith® Fenestrated AAA Endovascular Graft, which was commercially approved by FDA on April 4, 2012. Section I provides an update on results from the long-term post-approval study for the Zenith® Fenestrated AAA Endovascular Graft as of March 28, 2014. The long-term study…

In November, Cook is heading to the Wynn Resort in Las Vegas to celebrate the recent approval of Zenith Alpha Thoracic at VIVA15, and we want you to get hands on with the new device! In the Cook booth, you can try out hands-on deployment demos and ask our experts any questions you may have….

The 42nd annual VEITHsymposium is quickly approaching, and we’re excited to connect with you in the Cook Pavilion and Educational Suite. This year, you’ll be able to relax and connect with colleagues and explore our devices in a whole new way. Don’t miss these luncheons in the Cook Educational Suite Join us in the Bryant…

Bloomington, Ind. ─ Cook Medical has received premarket approval from the U.S. Food and Drug Administration (FDA) for its lower-profile Zenith Alpha™ Thoracic Endovascular Graft. Zenith Alpha Thoracic is indicated for the endovascular treatment of patients with isolated lesions of the descending thoracic aorta (not including dissections) having vascular anatomy suitable for endovascular repair1. The approval…

Cook is getting ready for the Society for Vascular Surgery’s 2015 Vascular Annual Meeting, which will take place June 17-20. Hundreds of physicians from around the world will gather in Chicago for one of the premier meetings for vascular health professionals. This year, the society received a record 705 abstract and video submissions, which should…

TM Mastracci MD Royal Free London NHS Foundation Trust Assessing the predictive value of a completion angiogram on the long-term durability of EVAR is a task that has only recently been requested of endovascular providers. Now that the endovascular community has proven that endovascular aneurysm repair is safe and effective in the short term1- 3…

Choose genuine Zenith accessories to help you provide a durable aortic repair.  

How do we address the chronic nature of aortic disease? That simple question is creating a stir among your vascular colleagues and forcing physicians to ask some tough questions: Should the progression of aortic disease change a physician’s approach to endovascular aortic repair? What is considered a durable aortic repair? How does a physician provide…

Abstract Cook is pleased to provide you with this clinical update on the Zenith® Fenestrated AAA Endovascular Graft, which was commercially approved by FDA on April 4, 2012. Section I provides an update on results from the long-term post-approval study for the Zenith Fenestrated AAA Endovascular Graft as of March 28, 2013. The long-term study…

Abstract Cook is pleased to provide you with this clinical update on the Zenith® TX2® TAA which was commercially approved by FDA on May 21, 2008. Section I provides the results from the completed multi-center clinical trial, reflecting final data received as of February 23, 2012. Briefly, the study was designed to compare thoracic aneurysm/ulcer treatment with…

A Supplement to Endovascular Today, Nov., 2013 sponsored by Cook Medical “The understanding of the progressive nature of aortic disease is evolving; therefore, the approach to endovascular aneurysm repair (EVAR) must also evolve. As a chronic condition that requires long-term management, the ability to achieve a durable repair becomes the central consideraton and objective. This…

What are the basic requirements to start a Zenith Fenestrated program? You must be a current Zenith Flex AAA Endovascular Graft user and have performed a minimum of 40 AAA procedures in your medical facility within the last 12 months. You must have access to an advanced imaging suite. You must have access to a fixed…

ABSTRACT On May 23, 2003, the Zenith® AAA Endovascular Graft received FDA approval based upon results of the U.S. clinical study, which included 351 patients. These data provided a prospective evaluation of clinical and radiographic performance related to safety and effectiveness. The study examined freedom from mortality, rupture, and open surgical conversion. In addition, the…